Online tools for optimizing seniors’ medication use
Deprescribing is the planned and supervised process of reducing or stopping a medication that may be causing harm or no longer be of benefit.
The Bruyère Deprescribing Guidelines Research Team, a partner of Ontario CLRI, have created bilingual tools and resources to help health-care professionals and residents make shared decisions on whether or not a medication is still the right fit:
- Five evidence-based guidelines that help health-care providers make informed assessments of a resident’s medication and explore possibilities for non-drug treatments.
- Pamphlets that empower residents to engage in their health care. These pamphlets provide key questions residents can ask their care team about their medications and explain deprescribing in plain language.
Studies on the making of the guidelines and algorithms have been published in Canadian Family Physician. The studies detail the process of gathering evidence and consulting primary care professionals for developing, reviewing and endorsing the guidelines.
Deprescribing.org was created by Dr. Barbara Farrell and Dr. Cara Tannenbaum a pharmacist and physician respectively who are concerned with the rising use of medications in the aging population.
The development of the algorithms was supported by the Ontario Pharmacy Research Collaboration (OPEN) and the Canadian Institutes of Health Research (CIHR).
Visit to learn more about deprescribing tools and resources.
This webinar highlights common elements of the deprescribing process and demonstrate approaches to engaging patients through shared decision-making.
This webinar highlights research that explores how pharmacists practicing in community settings can embrace their roles as key partners in deprescribing as one strategy for tackling the global problem of medication-related harm.
This webinar discusses how major depression can be difficult to treat, and how clinicians can sometimes feel constrained in choices of how to treat it (i.e., medications vs talk therapy). Other modalities with strong supporting evidence are presented along with suggestions on how these can be integrated into a deprescribing decision tree.
This article originally appeared in AdvantAge Ontario and discusses deprescribing for LTC homes.